SCHEMBL11976501

SCHEMBL11976501

c1cc(-c2cc(-c3ccncc3)cc(-c3ccncc3)c2)cc(-c2nccc3ccccc23)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.48
NPC1 O15118 5/20 0.48
RAB9A P51151 5/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
GPR55 Q9Y2T6 1/20 0.48
MAPT P10636 6/20 0.48
KMT2A Q03164 2/20 0.48
GLA P06280 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
PIK3CA P42336 1/20 0.43
NOTUM Q6P988 1/20 0.42
MAPK1 P28482 3/20 0.42
ALDH1A1 P00352 3/20 0.42
HPGD P15428 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
MAPK11 Q15759 2/20 0.42
MAPK14 Q16539 2/20 0.42
HSD17B10 Q99714 2/20 0.42
MAPK13 O15264 1/20 0.42
GCGR P47871 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17413753 0.93 PDGFRB (0.45) KDM4ENPC1RAB9AL3MBTL1GPR55
SCHEMBL11976498 0.92 KDM4E (0.55) KDM4ENPC1RAB9AL3MBTL1GPR55
SCHEMBL3141880 0.90 KDM4E (0.57) KDM4ENPC1RAB9AL3MBTL1GPR55
SCHEMBL29607745 0.88 KDM4E (0.57) KDM4ENPC1RAB9AL3MBTL1GPR55
SCHEMBL17449880 0.88 KDM4E (0.57) KDM4ENPC1RAB9AL3MBTL1GPR55
SCHEMBL11976500 0.85 KDM4E (0.55) KDM4ENPC1RAB9AL3MBTL1GPR55
SCHEMBL12215975 0.85 KDM4E (0.57) KDM4ENPC1RAB9AL3MBTL1GPR55
SCHEMBL18272707 0.84 KDM4E (0.51) KDM4ENPC1RAB9AL3MBTL1GPR55
SCHEMBL13103964 0.84 TDO2 (0.49) KDM4ENPC1RAB9AL3MBTL1GPR55
SCHEMBL17945862 0.83 KDM4E (0.50) KDM4ENPC1RAB9AL3MBTL1GPR55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2492276-B1 METAL COMPLEX, POLYMER, AND ELEMENT OBTAINED USING SAME SUMITOMO CHEMICAL CO (JP) 2014-10-08 EP disclosed
EP-2492276-A1 METAL COMPLEX, POLYMER, AND ELEMENT OBTAINED USING SAME Sumitomo Chemical Company, Limited (JP) 2012-08-29 EP disclosed
US-20120205585-A1 METAL COMPLEX, POLYMER COMPOUND AND DEVICE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-08-16 US disclosed
US-20120205585-A1 METAL COMPLEX, POLYMER COMPOUND AND DEVICE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120205585-A1 METAL COMPLEX, POLYMER COMPOUND AND DEVICE USING THE SAME HDAC10, EMG1, PRMT1 KDM4E 1254/4885NPC1 1597/4885RAB9A 470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.